RS70704A - Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping - Google Patents

Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping

Info

Publication number
RS70704A
RS70704A YU70704A YUP70704A RS70704A RS 70704 A RS70704 A RS 70704A YU 70704 A YU70704 A YU 70704A YU P70704 A YUP70704 A YU P70704A RS 70704 A RS70704 A RS 70704A
Authority
RS
Serbia
Prior art keywords
reduced risk
sustained
dose dumping
controlled release
delivery system
Prior art date
Application number
YU70704A
Other languages
English (en)
Inventor
M. Zahirul I. Khan
Aleksandra Krajačić
Zdravka Knežević
Snježana Vodobija-Mandić
Original Assignee
Pliva Istraživanje I Razvoj D.O.O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Istraživanje I Razvoj D.O.O. filed Critical Pliva Istraživanje I Razvoj D.O.O.
Publication of RS70704A publication Critical patent/RS70704A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Preparat sa odloženim/ regulisanim otpuštanjem leka sa smanjenim rizikom od preteranog doziranja i neželjenih efekata se sastoji od dve komponente: komponenta (a) se sastoji od framaceutski aktivne materije i vodonerastvorljivog, ali vodopropustljivog polimera, dok se komponenta (b) sastoji od farmaceutski aktivne materije i hidrofobne materije. Promenom odnosa farmaceutski aktivne materije i vodonerastvorljivog, ali vodopropustljivog polimera koji su sadržani u komponenti (a) i/ili odnosa farmaceutski aktivne materije i hidrofobne materije koji su sadržani u komponenti (b), može se lako realizovati idealna brzina otpuštanja sa smanjenim rizikom od preteranog doziranja i neželjenih efekata.
YU70704A 2002-02-11 2002-03-27 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping RS70704A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20020124A HRP20020124A2 (en) 2002-02-11 2002-02-11 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
PCT/HR2002/000018 WO2003074033A1 (en) 2002-02-11 2002-03-27 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping

Publications (1)

Publication Number Publication Date
RS70704A true RS70704A (en) 2006-10-27

Family

ID=27772919

Family Applications (1)

Application Number Title Priority Date Filing Date
YU70704A RS70704A (en) 2002-02-11 2002-03-27 Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping

Country Status (17)

Country Link
US (1) US20050118266A1 (sr)
EP (1) EP1474112A1 (sr)
JP (1) JP2006507216A (sr)
AU (1) AU2004205184A1 (sr)
BG (1) BG108870A (sr)
CA (1) CA2476050A1 (sr)
CZ (1) CZ2004931A3 (sr)
EE (1) EE200400110A (sr)
HR (1) HRP20020124A2 (sr)
HU (1) HUP0500097A3 (sr)
IS (1) IS7386A (sr)
NO (1) NO20043818L (sr)
PL (1) PL371787A1 (sr)
RS (1) RS70704A (sr)
RU (1) RU2004127237A (sr)
SK (1) SK3302004A3 (sr)
WO (1) WO2003074033A1 (sr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2244324B1 (es) * 2004-03-25 2006-11-16 Ferrer Internacional, S.A. Composiciones diureticas de liberacion prolongada.
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
JP2008525313A (ja) * 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
DE102006051020A1 (de) * 2006-10-26 2008-04-30 Evonik Röhm Gmbh Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung
NO2197534T3 (sr) 2007-09-25 2018-08-04
US8926490B2 (en) * 2008-09-24 2015-01-06 Neosync, Inc. Systems and methods for depression treatment using neuro-EEG synchronization therapy
WO2011017466A1 (en) 2009-08-06 2011-02-10 Neosync, Inc. Systems and methods for modulating the electrical activity of a brain using neuro-eeg synchronization therapy
WO2011036114A1 (en) * 2009-09-25 2011-03-31 Novartis Ag Oral pharmaceutical composition comprising diclofenac
EP2498857B1 (en) 2009-11-12 2020-04-29 Neosync, INC. Systems and methods for neuro-eeg synchronization
EP2540318B1 (en) 2010-02-22 2018-10-24 Daiichi Sankyo Company, Limited Sustained-release solid preparation for oral use
EP2540294B1 (en) 2010-02-22 2016-08-03 Daiichi Sankyo Company, Limited Sustained-release solid preparation for oral use
CA2792523C (en) * 2010-03-09 2018-01-09 Alkermes Pharma Ireland Limited Alcohol resistant enteric pharmaceutical compositions
ES2706994T3 (es) 2012-09-03 2019-04-02 Daiichi Sankyo Co Ltd Composición farmacéutica de liberación prolongada de administración oral que contiene clorhidrato de hidromorfona
US20150238451A1 (en) * 2012-10-19 2015-08-27 Wockhardt Limited Pharmaceutical compositions of diclofenac or salts thereof
US10588576B2 (en) 2014-08-15 2020-03-17 Neosync, Inc. Methods and device for determining a valid intrinsic frequency
JP1602547S (sr) 2017-01-17 2018-04-23

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN156886B (sr) * 1981-08-22 1985-11-30 Council Scient Ind Res
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
NZ231281A (en) * 1988-11-08 1991-01-29 Takeda Chemical Industries Ltd Sustained release pharmaceutical preparations comprising the active agent dispersed in a solid matrix of a fatty acid ester of a polyglycerol
US4948581A (en) * 1989-02-17 1990-08-14 Dojin Iyaku-Kako Co., Ltd. Long acting diclofenac sodium preparation
JP2572673B2 (ja) * 1990-07-25 1997-01-16 エスエス製薬株式会社 徐放性錠剤
US5635200A (en) * 1992-10-16 1997-06-03 Glaxo Group Limited Taste-making compositions of ranitidine
US6183778B1 (en) * 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19524753A1 (de) * 1995-07-07 1997-01-23 Lohmann Therapie Syst Lts Schichttablette zur kontrollierten Freisetzung von Wirkstoffen
DE69713948D1 (de) * 1996-04-23 2002-08-22 Janssen Pharmaceutica Nv Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid
NZ330739A (en) * 1996-05-20 1999-06-29 Janssen Pharmaceutica Nv Particulate solid dispersion of itraconazole and a water soluble polymer
US6294199B1 (en) * 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin

Also Published As

Publication number Publication date
RU2004127237A (ru) 2005-04-20
CA2476050A1 (en) 2003-09-12
AU2004205184A1 (en) 2005-03-03
PL371787A1 (en) 2005-06-27
CZ2004931A3 (cs) 2005-03-16
BG108870A (en) 2005-12-30
HUP0500097A2 (hu) 2005-07-28
WO2003074033A8 (en) 2004-07-08
EE200400110A (et) 2004-10-15
SK3302004A3 (sk) 2005-04-01
US20050118266A1 (en) 2005-06-02
EP1474112A1 (en) 2004-11-10
JP2006507216A (ja) 2006-03-02
NO20043818L (no) 2004-09-30
WO2003074033A1 (en) 2003-09-12
HUP0500097A3 (en) 2008-04-28
IS7386A (is) 2004-08-05
HRP20020124A2 (en) 2003-10-31

Similar Documents

Publication Publication Date Title
RS70704A (en) Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
WO2007008752A3 (en) Sustained release pharmaceutical compositions for highly water soluble drugs
WO2006017852A3 (en) Pharmaceutical compositions for controlled release delivery of biologically active compounds
WO2000040203A3 (en) Polymeric delivery agents and delivery agent compounds
TW200605915A (en) Drug delivery compositions
ATE251449T1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
WO2004056311A3 (en) Stimuli-responsive systems for controlled drug delivery
WO2001052823A3 (en) Compositions to effect the release profile in the transdermal administration of drugs
HRP20050077B1 (hr) Postupci i oblici doziranja za kontrolirano oslobađanje paliperidona
IL153297A0 (en) Compounds and compositions for delivering active agents
DE69721481D1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
CA2440207A1 (en) Drug delivery system
HRP20020929A2 (en) Sustained release pharmaceutical cmpositions for parenteral administration of hydrophilic compounds
HK1087031A1 (en) Subcutaneous implants having limited initial release of the active principle and subsequent linearlyvarying extended release thereof
WO2003035051A3 (en) The use of proton sequestering agents in drug formulations
EP2308479A3 (en) Compounds and compositions for delivering active agents
TW200635616A (en) Organic compounds
EP1569664A4 (en) BIOERODABLE POLY (ORTHO ESTERS) PREPARED FROM DI (CETENE ACETALS) BASED ON DIOXANE AND COPOLYMER SEQUENCES CONTAINING THE SAME
GB0222612D0 (en) Controlled delivery system for bioactive substances
WO2002015959A3 (en) Compounds and compositions for delivering active agents
MXPA05007717A (es) Liberacion controlada de agentes altamente solubles.
AU2001235783A1 (en) Therapeutic compositions for pulmonary delivery
WO2007033152A3 (en) Composition, system and method for modulating release kinetics in implantable drug delivery devices by modifying drug solubility
WO2007016350A3 (en) Modified release tablet formulations with enhanced mechanical properties
WO2008015232A8 (en) Subcutaneous implants releasing an active principle over an extended period of time